| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |